Jean Y. Tang MD PhD

Dermatologist, General dermatologist, Dermatologic oncologist, Cutaneous oncology specialist

Associate Professor of Dermatology at the Stanford University Medical Center

Skin Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

General Dermatology Clinic

  • 450 Broadway Street
  • Redwood City, CA 94063
  • Phone: 650-723-6316
Learn More About the Clinic Getting Here Make An Appointment

General Dermatology Clinic in Redwood City

  • 450 Broadway Street
  • Redwood City, CA 94063
  • Phone: 650-723-6316
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University Hospital and Clinics - Dermatology Department (2007) CA

Internship: Santa Clara Valley Medical Center (2004) CA

Medical Education: Stanford University Hospital and Clinics - Dermatology Department (2003) CA

Fellowship: UCSF - Dept of Epidemiology and Biostatistics (2008) CA

Board Certification: Dermatology, American Board of Dermatology (2007)

Fellow, Univ of Calif, San Francisco, KL2 Clinical Research (2009)

Resident, Stanford University, Dermatology (2007)

Intern, Santa Clara Valley, Medicine (2004)

PhD, Stanford University, Biophysics (2003)

MD, Stanford University, Medicine (2003)

BA, UC Berkeley, Biochemistry (1995)

Honors & Awards

Scholar-Innovator, Harrington Discovery Center (2014-2016)

Clinical Investigator Award, Damon Runyon (July 1 2011 - July 2014)

K23 Career Development Award, National Institutes of Health (2009 - 2013)

Health Services Investigator Award, American Skin Association (2009)

Young Investigator Award, Prevent Cancer Organization (2007-2009)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma
Kim, D. D., Tang, J. Y., & Ioannidis, J. Pa. (2014). Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. JOURNAL OF CLINICAL EPIDEMIOLOGY, 67(4), 391-400.

Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Kim, D. J., Kim, J., Spaunhurst, K., Montoya, J., Khodosh, R., & Tang, J. Y. (2014). Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 32(8), 745-751.

Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative
Gamba, C. A., Swetter, S. M., Stefanick, M. L., Kubo, J., Desai, M., & Tang, J. Y. (2013). Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative. CANCER, 119(8), 1562-1569.

GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas
Atwood, S. X., Li, M., Lee, A., Tang, J. Y., & Oro, A. E. (2013). GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. NATURE, 494(7438), 484-488.

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
Kim, J., Aftab, B. T., Tang, J. Y., Kim, D., Lee, A. H., & Rudin, C. M. (2013). Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists. CANCER CELL, 23(1), 23-34.

Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Yauch, R. L., Lindgren, J., & Epstein, E. H. (2012). Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. NEW ENGLAND JOURNAL OF MEDICINE, 366(23), 2180-2188.

Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative
Brasky, T. M., Liu, J., White, E., Peters, U., Potter, J. D., & Wactawski-Wende, J. (2014). Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative. INTERNATIONAL JOURNAL OF CANCER, 135(8), 1869-1883.

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.
Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., & Cho, Y.-J. (2014). Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature medicine, 20(7), 732-740.

Lack of efficacy with 1064-nm neodymium: yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial
Hollmig, S. T., Rahman, Z., Henderson, M. T., Rotatori, R. M., Gladstone, H., & Tang, J. Y. (2014). Lack of efficacy with 1064-nm neodymium: yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(5), 911-917.

The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome
Ally, M. S., Tang, J. Y., Joseph, T., Thompson, B., Lindgren, J., & Epstein, E. H. (2014). The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome. JAMA DERMATOLOGY, 150(5), 542-545.

Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome
Tang, J. Y., Chiou, A. S., Mackay-Wiggan, J. M., Aszterbaum, M., Chanana, A. M., & Epstein, E. H. (2014). Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome. CANCER PREVENTION RESEARCH, 7(3), 292-299.

Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative
Kubo, J. T., Henderson, M. T., Desai, M., Wactawski-Wende, J., Stefanick, M. L., & Tang, J. Y. (2014). Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative. CANCER CAUSES & CONTROL, 25(1), 1-10.

Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population-Based Study
Fu, T., Keiser, E., Linos, E., Rotatori, R. M., Sainani, K., & Tang, J. Y. (2014). Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population-Based Study. PEDIATRIC DERMATOLOGY, 31(1), 21-26.

Quantifying Soft Tissue Loss in Facial Aging: A Study in Women Using Magnetic Resonance Imaging
Wysong, A., Joseph, T., Kim, D., Tang, J. Y., & Gladstone, H. B. (2013). Quantifying Soft Tissue Loss in Facial Aging: A Study in Women Using Magnetic Resonance Imaging. DERMATOLOGIC SURGERY, 39(12), 1895-1902.

Lower Skin Cancer Risk in Women with Higher Body Mass Index: The Women's Health Initiative Observational Study
Tang, J. Y., Henderson, M. T., Hernandez-Boussard, T., Kubo, J., Desai, M., & Stefanick, M. L. (2013). Lower Skin Cancer Risk in Women with Higher Body Mass Index: The Women's Health Initiative Observational Study. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 22(12), 2412-2415.

Role of aspirin and non-aspirin NSAIDs in preventing melanoma.
Ally, M. S., Swetter, S. M., & Tang, J. Y. (2013). Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Future oncology , 9(11), 1671-1674.

Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.
Ally, M. S., Wysong, A., Tang, J. Y., & Aasi, S. (2013). Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome. Dermatologic surgery , 39(9), 1413-1414.

Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Gamba, C. S., Stefanick, M. L., Shikany, J. M., Larson, J., Linos, E., & Tang, J. Y. (2013). Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 22(9), 1509-1519.

Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin.
Ally, M. S., Tang, J. Y., & Arron, S. T. (2013). Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. journal of investigative dermatology, 133(6), 1456-1458.

The use of aprepitant in brachioradial pruritus.
Ally, M. S., Gamba, C. S., Peng, D. H., & Tang, J. Y. (2013). The use of aprepitant in brachioradial pruritus. JAMA dermatology (Chicago, Ill.), 149(5), 627-628.

Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011.
Wysong, A., Aasi, S. Z., & Tang, J. Y. (2013). Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA dermatology , 149(5), 615-616.

Nonmelanoma Skin Cancer Visits and Procedure Patterns in a Nationally Representative Sample: National Ambulatory Medical Care Survey 1995-2007
Wysong, A., Linos, E., Hernandez-Boussard, T., Arron, S. T., Gladstone, H., & Tang, J. Y. (2013). Nonmelanoma Skin Cancer Visits and Procedure Patterns in a Nationally Representative Sample: National Ambulatory Medical Care Survey 1995-2007. DERMATOLOGIC SURGERY, 39(4), 596-602.

New Onset of Keratoacanthomas After Vismodegib Treatment for Locally Advanced Basal Cell Carcinomas: A Report of 2 Cases
Aasi, S., Silkiss, R., Tang, J. Y., Wysong, A., Liu, A., & Chang, A. L. S. (2013). New Onset of Keratoacanthomas After Vismodegib Treatment for Locally Advanced Basal Cell Carcinomas: A Report of 2 Cases. JAMA DERMATOLOGY, 149(2), 242-243.

Factors affecting sunscreen use and sun avoidance in a US national sample of organ transplant recipients
Mihalis, E. L., Wysong, A., Boscardin, W. J., Tang, J. Y., Chren, M. M., & Arron, S. T. (2013). Factors affecting sunscreen use and sun avoidance in a US national sample of organ transplant recipients. BRITISH JOURNAL OF DERMATOLOGY, 168(2), 346-353.

The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma
Hollmig, S. T., Kirkland, E. B., Henderson, M. T., Tang, J. Y., & Gladstone, H. B. (2012). The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma. DERMATOLOGIC SURGERY, 38(12), 1922-1929.

Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?
Gamba, C. A., Wysong, A., Million, L., Aasi, S., Kim, J., & Tang, J. Y. (2012). Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?. JOURNAL OF CLINICAL ONCOLOGY, 30(32), E333-E336.

Vitamin D in cutaneous carcinogenesis Part II
Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis Part II. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 67(5).

Vitamin D in cutaneous carcinogenesis Part I
Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis Part I. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 67(5).

Does a History of Eczema Predict a Future Basal Cell Carcinoma?
Gamba, C. A., & Tang, J. Y. (2012). Does a History of Eczema Predict a Future Basal Cell Carcinoma?. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 132(11), 2497-2499.

Sunscreen use in NCAA collegiate athletes: Identifying targets for intervention and barriers to use
Wysong, A., Gladstone, H., Kim, D., Lingala, B., Copeland, J., & Tang, J. Y. (2012). Sunscreen use in NCAA collegiate athletes: Identifying targets for intervention and barriers to use. PREVENTIVE MEDICINE, 55(5), 493-496.

Nanoelectroablation therapy for murine basal cell carcinoma
Nuccitelli, R., Kevin Tran, K., Athos, B., Kreis, M., Nuccitelli, P., & Tang, J. Y. (2012). Nanoelectroablation therapy for murine basal cell carcinoma. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 424(3), 446-450.

Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16
Spaunhurst, K. M., Hogendorf, A. M., Smith, F. Jd., Lingala, B., Schwartz, M. E., & Tang, J. Y. (2012). Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. BRITISH JOURNAL OF DERMATOLOGY, 166(4), 875-878.

Ulcers and stellate scars on bilateral ankles.
Spaunhurst, K. M., Wysong, A., Kim, J., & Tang, J. Y. (2012). Ulcers and stellate scars on bilateral ankles. Archives of dermatology, 148(3), 385-390.

Vitamin D in cutaneous carcinogenesis: part II.
Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis: part II. Journal of the American Academy of Dermatology, 67(5), 817.e1-11; quiz 827-8.

Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006
Linos, E., Keiser, E., Kanzler, M., Sainani, K. L., Lee, W., & Tang, J. Y. (2012). Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. CANCER CAUSES & CONTROL, 23(1), 133-140.

Reliability and prevalence of digital image skin types in the United States: Results from National Health and Nutrition Examination Survey 2003-2004
Keiser, E., Linos, E., Kanzler, M., Lee, W., Sainani, K. L., & Tang, J. Y. (2012). Reliability and prevalence of digital image skin types in the United States: Results from National Health and Nutrition Examination Survey 2003-2004. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 66(1), 163-165.

Emerging Treatments and Signaling Pathway Inhibitors
Tang, J. Y., & Marghoob, A. A. (2011). Emerging Treatments and Signaling Pathway Inhibitors. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 30(4), S14-S18.

Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma
Tang, J. Y. (2011). Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 30(4), S6-S9.

Correlates of low bone mass in children with generalized forms of epidermolysis bullosa
Bruckner, A. L., Bedocs, L. A., Keiser, E., Tang, J. Y., Doernbrack, C., & Bachrach, L. K. (2011). Correlates of low bone mass in children with generalized forms of epidermolysis bullosa. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), 1001-1009.

Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women's Health Initiative Randomized Trials
Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski-Wende, J., Keiser, E., & Stefanick, M. L. (2011). Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women's Health Initiative Randomized Trials. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 103(19), 1469-1475.

Subcutaneous Nodules in an Elderly Patient Necrobiotic xanthogranuloma
Fu, T., Zwerner, J., Kim, J., & Tang, J. (2011). Subcutaneous Nodules in an Elderly Patient Necrobiotic xanthogranuloma. ARCHIVES OF DERMATOLOGY, 147(10), 1215-1220.

Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial
Tang, J. Y., Fu, T., Leblanc, E., Manson, Ja. E., Feldman, D., & Stefanick, M. L. (2011). Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial. JOURNAL OF CLINICAL ONCOLOGY, 29(22), 3078-3084.

Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness
Linos, E., Keiser, E., Fu, T., Colditz, G., Chen, S., & Tang, J. Y. (2011). Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. CANCER CAUSES & CONTROL, 22(7), 1067-1071.

Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
Tang, T., Tang, J. Y., Li, D., Reich, M., Callahan, C. A., & de Sauvage, F. J. (2011). Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened. CLINICAL CANCER RESEARCH, 17(10), 3378-3387.

Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations
Fu, T., Leachman, S. A., Wilson, N. J., Smith, F. Jd., Schwartz, M. E., & Tang, J. Y. (2011). Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 131(5), 1025-1028.

Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas
Tang, J. Y., Xiao, T. Z., Oda, Y., Chang, K. S., Shpall, E., & Epstein, E. H. (2011). Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas. CANCER PREVENTION RESEARCH, 4(5), 744-751.

Association of facial skin aging and vitamin D levels in middle-aged white women
Chang, A. L. S., Fu, T., Amir, O., & Tang, J. Y. (2010). Association of facial skin aging and vitamin D levels in middle-aged white women. CANCER CAUSES & CONTROL, 21(12), 2315-2316.

High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome
Tang, J. Y., Wu, A., Linos, E., Parimi, N., Lee, W., & Epstein, E. H. (2010). High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome. ARCHIVES OF DERMATOLOGY, 146(10), 1105-1110.

Novel investigational drugs for basal cell carcinoma
So, P.-L., Tang, J. Y., & Epstein, E. H. (2010). Novel investigational drugs for basal cell carcinoma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19(9), 1099-1112.

Association of Prediagnostic Serum Vitamin D Levels with the Development of Basal Cell Carcinoma
Asgari, M. M., Tang, J., Warton, M. E., Chren, M.-M., Quesenberry, C. P., & Friedman, G. D. (2010). Association of Prediagnostic Serum Vitamin D Levels with the Development of Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(5), 1438-1443.

Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., & Beachy, P. A. (2010). Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth. CANCER CELL, 17(4), 388-399.

Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men
Tang, J. Y., Parimi, N., Wu, A., Boscardin, W. J., Shikany, J. M., & Bauer, D. C. (2010). Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. CANCER CAUSES & CONTROL, 21(3), 387-391.

Medical Management of Advanced or Metastatic Basal Cell Carcinomas
Jean Y Tang, & Ervin H. Epstein. (2010). Medical Management of Advanced or Metastatic Basal Cell Carcinomas. AccessMedicine from McGraw-Hill.

Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1(+/-) Humans and Mice
Tang, J. Y., Aszterbaum, M., Athar, M., Barsanti, F., Cappola, C., & Epstein, E. H. (2010). Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1(+/-) Humans and Mice. CANCER PREVENTION RESEARCH, 3(1), 25-34.

Statin use and risk of basal cell carcinoma
Asgari, M. A., Tang, J., Epstein, E. H., Chren, M.-M., Warton, E. M., & Friedman, G. D. (2009). Statin use and risk of basal cell carcinoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(1), 66-72.

Novel Hedgehog pathway targets against basal cell carcinoma
Tang, J. Y., So, P.-L., & Epstein, E. H. (2007). Novel Hedgehog pathway targets against basal cell carcinoma. TOXICOLOGY AND APPLIED PHARMACOLOGY, 224(3), 257-264.

Xeroderma pigmentosum group C in an isolated region of Guatemala
Cleaver, J. E., Feeney, L., Tang, J. Y., & Tuttle, P. (2007). Xeroderma pigmentosum group C in an isolated region of Guatemala. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127(2), 493-496.

Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage
Rieger, K. E., Hong, W. J., Tusher, V. G., Tang, J., Tibshirani, R., & Chu, G. (2004). Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(17), 6635-6640.

Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase
Cong, F., Tang, J., Hwang, B. J., Vuong, B. Q., Chu, G., & Goff, S. P. (2002). Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(38), 34870-34878.

Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein
Tang, J., & Chu, G. (2002). Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA REPAIR, 1(8), 601-616.

Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis
Tang, J. Y., Hwang, B. J., Ford, J. M., Hanawalt, P. C., & Chu, G. (2000). Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. MOLECULAR CELL, 5(4), 737-744.

INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE AND MODIFICATION OF HDL APOLIPOPROTEINS BY ALDEHYDES
McCall, M., Tang, J. Y., Bielicki, J. K., & Forte, T. M. (1995). INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE AND MODIFICATION OF HDL APOLIPOPROTEINS BY ALDEHYDES. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 15(10), 1599-1606.